India, China spar over legacy of Sowa-Rigpa, medicinal system similar to Ayurveda
“India has approached Unesco seeking the enlisting of the Sowa Rigpa as its ‘intangible cultural heritage’. China has raised an objection to it,” an official said.
New Delhi: India and China are at loggerheads over the legacy of one of the oldest systems of traditional medicine, known as Sowa-Rigpa, which has similarities with Ayurveda.
India has sought recognition of the ancient medicinal tradition as its “intangible cultural heritage”, a claim contested by China at a global forum, sources said.
Sowa-Rigpa is a traditional Tibetan system of medicine practised in India’s Himalayan belt. It is popular in Sikkim, Arunachal Pradesh, West Bengal’s Darjeeling, Himachal Pradesh and the Union Territory of Ladakh. “India has approached Unesco seeking the enlisting of the Sowa Rigpa as its ‘intangible cultural heritage’. China has raised an objection to it,” an official said.
An Indian delegation is strongly pushing the country’s application based on detailed documents and evidence provided by the Ayush Ministry which has been working closely with the Ministry of External Affairs on the matter, officials said.
The move comes in the backdrop of the Modi government promoting the traditional medicine system, one of the oldest surviving medicine systems in the world.
The Union Cabinet on November 20 approved the setting up of the National Institute for Sowa-Rigpa (NISR) in Leh as an autonomous organisation. This is perhaps one of the first decisions taken by the Union Cabinet on Ladakh’s development after it became a Union Territory on October 31.
Read Also: India, China to cooperate in RnD for promoting Indian generic drugs, Chinese APIs
The theory and practices of Sowa Rigpa are similar to Ayurveda and include a few principles of the traditional Chinese system of medicine. The fundamental textbook ‘Rgyud-Bzi’ of Sowa Rigpa is believed to have been taught by Buddha himself and is closely linked with Buddhist philosophy.
The establishment of the NISR as an autonomous body under the Ministry of Ayush has been approved at an estimated cost of Rs 47.25 crore. According to an official, setting up of NISR would provide an impetus to the revival of Sowa-Rigpa in the Indian sub-continent and provide opportunities for students of the traditional medicinal system not only in India but also from other countries.
Read Also: Revised drug law to pave way for cheap Indian generic medicines in China: Report
Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers. Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd